Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 4, 2006
Anti-angiogenic and anti-HER therapyGiampietro Gasparini, Roberta Sarmiento, Raffaele Longo
The International Journal of Biological Markers|January 3, 2013
Antiangiogenic therapy of colorectal cancer: state of the art, challenges and new approachesRoberta Sarmiento, Raffaele Longo, Giampietro Gasparini
Critical Reviews in Oncology/Hematology|March 13, 2013
The contribution of targeted therapy to the neoadjuvant chemoradiation of rectal cancerFrancesco Torino, Roberta Sarmiento, Giampietro Gasparini
The Lancet. Oncology|October 14, 2003
Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?Giampietro Gasparini, Raffaele Longo, Roberta Sarmiento, et al.
Critical Reviews in Oncology/Hematology|March 12, 2004
Antiangiogenic strategies, compounds, and early clinical results in breast cancerAlessandro Morabito, Roberta Sarmiento, Paola Bonginelli, et al.
Expert Opinion on Investigational Drugs|April 9, 2010
Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumabRaffaele Longo, Mario D'Andrea, Roberta Sarmiento, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2009
Antiangiogenic therapies in breast cancerRoberta Sarmiento, Mario Rosario D'Andrea, Francesca Cacciamani, et al.
Oncology Reports|December 5, 2003
Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastomaAlessandro Morabito, Massimo Fanelli, Guido Carillio, et al.
Recenti Progressi in Medicina|December 20, 2002
[Innovative treatment in oncology]Barbara Capaccetti, Paola Bonginelli, Roberta Sarmiento, et al.
Clinical Breast Cancer|March 15, 2003
Prognostic and predictive indicators in operable breast cancerAlessandro Morabito, Elena Magnani, Massimo Gion, et al.
Pageof 7